Publikationen in Zusammenarbeit mit Forschern von University of Liverpool (37)

2024

  1. Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis

    European Journal of Clinical Investigation

  2. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study

    Internal and Emergency Medicine, Vol. 19, Núm. 7, pp. 1941-1948

  3. Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 656-666

2023

  1. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis

    Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662

  3. Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  4. Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis

    European Journal of Internal Medicine

  5. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    American Heart Journal, Vol. 258, pp. 1-16

  6. Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry

    European Journal of Internal Medicine, Vol. 107, pp. 60-65

  7. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

    Science of the Total Environment, Vol. 880

  8. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

    Biomedicine and Pharmacotherapy, Vol. 158

  9. Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia

    Heart and Lung, Vol. 59, pp. 61-66

  10. Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis

    Internal and Emergency Medicine, Vol. 18, Núm. 2, pp. 423-428

2022

  1. Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review

    Reviews in Cardiovascular Medicine, Vol. 23, Núm. 12

  2. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper

    Thrombosis and Haemostasis, Vol. 122, Núm. 10, pp. 1625-1652

  3. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 11, pp. 1844-1871

  4. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022

  5. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 5, pp. 721-728

  6. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system

    Frontiers in Cardiovascular Medicine

  7. Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program

    Medicina Clinica, Vol. 159, Núm. 4, pp. 177-182